In this article we summarize the experimental studies providing novel concepts for cell-enhancement strategies to aid the treatment of peripheral artery occlusive and ischemic heart disease.

Ischemic heart disease is the most common cause of death ... Depending on the symptoms and risk, treatment may be with medication, percutaneous coronary intervention (angioplasty) or coronary ...

Dr Matthew Molloy, GPSI in cardiology, explains the latest knowledge and best practice in the management of Ischaemic Heart ...

A new study has found that hormone replacement therapy, or HRT, used to alleviate the symptoms of the menopause, may be ...

for the treatment of ischemic heart failure of reduced ejection fraction (HFrEF). “This most recent meeting with PMDA had several important outcomes,” said Peter Altman, Ph.D., BioCardia’s President ...

After more than a decade of research, experts have revealed a worrying reality for people taking certain hormone medications ...

New study finds using oral combined continuous therapy was associated with increased risk of ischemic heart disease ...

Certain hormone replacement therapy (HRT) tablets containing both estrogen and progestogen are associated with a higher risk ...

Hormone replacement therapy helps relieve postmenopausal symptoms such as hot flushes and night sweats by replacing hormones ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...